NASDAQ
Karyopharm Therapeutics Inc. (KPTI) has a eps (diluted) of $-17.93 as of Wednesday, December 31, 2025. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.